Kerstin A. David
Technik-/Wissenschafts-/F&E-Leiter bei Indivumed GmbH
Profil
Kerstin A.
David is currently the Chief Scientific Officer at Indivumed GmbH.
Prior to this, she worked as an Assistant Professor at the University of Hamburg and the Cancer Research Center of Hawaii.
She holds a doctorate degree from the University of Hamburg.
Aktive Positionen von Kerstin A. David
| Unternehmen | Position | Beginn |
|---|---|---|
Indivumed GmbH
 Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
Ehemalige bekannte Positionen von Kerstin A. David
| Unternehmen | Position | Ende |
|---|---|---|
| Cancer Research Center of Hawaii | Corporate Officer/Principal | - |
| University of Hamburg | Corporate Officer/Principal | - |
Ausbildung von Kerstin A. David
| University of Hamburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
| Cancer Research Center of Hawaii |
